Plasmodium vivax causes over 100 million infections annually; 8-aminoquinoline drugs can clear the parasites, but may also cause hemolysis in patients with G6PD deficiency. PATH developed GeoDX, a computer program that estimates the P. vivax burden per health facility, the total quantity of G6PD tests per country, and associated costs.
Author(s): Kalnoky M, Luter N, Nowak S, Metzler M, Domingo G, Malaria Atlas Project at Oxford University
Corporate author(s): PATH, Malaria Atlas Project at Oxford University
Publication date: November 2017
473 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
This publication is part of the series ASTMH posters
Related regions: Global
- Emerging and epidemic diseases > Malaria
- Health technologies > Diagnostics
- Health technologies > Information and communication technologies
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA